New prostate cancer test means some men could avoid unnecessary treatment

OncoAssure co-founder Des O’Leary: 'By accurately identifying patients at higher risk of aggressive disease, our test equips clinicians to tailor treatment plans that can improve patient outcomes.' Picture: Vincent Hoban, UCD

A new test for prostate cancer developed by Irish and Swedish researchers better predicts the risks of the aggressive disease and means some men could avoid unnecessary treatment.

Prostate cancer is the most common non-skin cancer in men and the second leading cause of male cancer death worldwide.